Navigation Links
XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
Date:3/18/2009

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that it has entered into an asset purchase agreement with Bio-GAL Ltd, a private company, for the rights to a use patent on Recombinant Erythropoietin ("rHuEPO") for the prolongation of multiple myeloma ("MM") patients' survival and improvement of their quality of life.

MM is a severe plasma cell malignancy characterized by the accumulation and proliferation of clonal plasma cells in the marrow, leading to the gradual replacement of normal hematopoiesis.

David Grossman, XTL's co-Chief Executive Officer, commented, "This is a very exciting opportunity to acquire the rights for a potential treatment for a severe and incurable blood cancer. We at XTL are thrilled at this opportunity and expect to embark on a clinical trial with rHuEPO for the treatment of MM in the near term and hope to lead it to a successful outcome."

In accordance with the terms of the asset purchase agreement, XTL will issue Bio-GAL Ltd. ordinary shares representing just under 50% of the current issued and outstanding share capital of the Company. In addition, XTL will make milestone payments of approximately $10 million in cash upon the successful completion a Phase 2 clinical trial. The Company's Board of Directors may, in its sole discretion, issue additional ordinary shares to Bio-GAL Ltd in lieu of such milestone payment. XTL is also obligated to pay 1% royalties on net sales of the product. The closing of the transaction is subject to various conditions including XTL's and Bio-GAL's shareholders' approvals, as well as completion of a financing. Closing is expected to take place in the second or third quarter of 2009.

ABOUT ERYTHROPOIETIN (EPO)

Erythropoietin (EPO) is a glyco
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
2. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
3. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
4. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
5. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
6. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
7. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
9. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
10. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
11. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., China, Nov. 25 /PRNewswire-Asia-FirstCall/ -- Ch... or "the Company") (Nasdaq: CSKI ), a,leading ful...d producing,over-the-counter drugs in the People,s...he Company recently passed the Chinese National In...ogical Products ("ICPBP") examination,for two of i...
(Date:11/25/2009)...CK, N.J., Nov. 25 Swissray Interna...tal Radiography ( ddR ) systems, announced today t... Swiss Investor with a long term view towards grow...ion included all assets and intellectual property,...s of success and growth Swissray is now poised to ...
(Date:11/25/2009)... Nov. 25 Reportlinker.com announce...n its catalogue: ,, Pain Management - Global ...20/Pain-Management---Global-Trends.html ,, Wid...f pain management clinics, and the advent of new d...in management market. Healthcare reforms and reimb...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 1ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 2Too Many Bouncers Make Trampolines More Dangerous 47766 1Fewer New Pounds in Pregnancy Best for Obese Moms 47764 1Fewer New Pounds in Pregnancy Best for Obese Moms 47764 2Fewer New Pounds in Pregnancy Best for Obese Moms 47764 3
...alif., July 06, 2007 /PRNewswire-FirstCall/ --,Sup... Chief Medical,Officer, will present at the C.E. U...ference on Thursday, July 12, 2007 at the Mandarin...sentation at the C.E. Unterberg, Towbin Emerging,G...in at 3:30 p.m.,EDT. A live webcast of the present...
..., Mass.--(BUSINESS WIRE)--Jul 5, 2007 - GTC,Biothe...day that,Geoffrey Cox, Ph.D., GTC,s Chairman and C... 2007 at 9:00 a.m. during the C.E.,Unterberg, Towb...The conference is being held at the Mandarin Orien...007., The presentation will be webcast live and ca...
Other Medicine Technology:SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2
(Date:11/28/2009)...RNewswire/ -- Get ready for advanced visualizat...ine when Siemens introduces syngo. via(1)...ing of the Radiological Society of North America (...Place (Booth #825, East Building/Lakeside Center, ...ens, new imaging software for multimodality readin...
(Date:11/27/2009)...PRNewswire/ - Uploadable USB pedometers may be new...s. A combination of advanced accelerometer functio...g term concern over the accuracy of self-reported ...ward improved participation in a fitness program. ...wellness suppliers to integrate this technology. "...
(Date:11/27/2009)...France, Nov. 27 Team Garmin-Slipst... dedicated to ethical sporting and developing the ...day that it will become Team Garmin-Transitions wi...onsor of the team. Transitions Optical is the worl...ring the most advanced photochromic technology in ...
(Date:11/27/2009)...LE, Nov. 27 Allrecipes.com , th...sgiving traffic numbers, with more than 2.8 millio...a clear picture of what was served on the biggest ... meal in 2009 weighed in at 2,225 calories per ser... According to the Allrecipes site, Sweet Potato P...
(Date:11/26/2009)...Newswire/ -- With cold and flu season upon us, it,...s to control the spread of infections and avoid il...keep ourselves healthy, but to avoid transmitting ...S, CIC (certified in infection-control), nursing d...lth at Hospital for Special Surgery (HSS) in Manha...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...in increasing the blood pressure among the older p...rom stroke and heart disease, according to a new r...has been found that lonely people have blood press...re taken into account, said Louise Hawkley, Senior...
...t will travel all over the country with volunteers... bicycles to spread awareness about AIDS and how t... Express" will create awareness about the killer d... to have the second largest population of AIDS pat...
...r some healthy practices in classrooms, meant to b...urs a day. // This follows a study, which has indi...ant weight loss, as against sitting which can be c...sample and not ample! This unconventional approac...
...s or lymphatic filariasis (LF) as it is officially...sy on the 3,000-year-old mummified body of Natsef-... XI, revealed the presence of filarial worms. It i...otesquely swollen limbs, as well as fevers and pai...
...ds of many a watering mouth. Yet, by a quirk of fa...t away from star hotels and foreign trips, to land...tic, to say the least! Taking a trip down me...tly thrown the bird-flu threats to the summer wind...
...the market and minds of various people world over....mber of detox products are to be investigated by t...e BBC which drew its attention to some of their me...tox programme. Some detox products claim to enhanc...
Other Medicine News:Health News:Loneliness Results In High Blood Pressure In Elders 2Health News:Loneliness Results In High Blood Pressure In Elders 3Health News:A Unique Train To Spread Awareness About AIDS 2Health News:Welcome to ‘Stand Only’ Classrooms That Exercise The Brain And The Bod 2
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Finnpipette Fixed Volume, 20ul
Pipetman F1000
Finnpipette Focus Fixed Volume, 1ul
Medicine Products: